Home IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment
 

Keywords :   


IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment

2016-03-02 05:45:22| drugdiscoveryonline Home Page

IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced a collaboration with the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki to further the development of personalized medicine in cancer treatment

Tags: treatment medicine advance cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11kazu.boo BG
27.11 2
27.112493 33500 Bloodborne gecco
27.11
27.11
27.11Yuki
27.11RG SPECIAL COATING]
27.11DIALOGUE
More »